Skip to content

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Why Subscribe
About Us
Accreditation
Library
Live Events
Sign Up / Login

Library

By pinki shah / May 14, 2022

Speciality

Author / Speaker

Title of Presentation

Type of Media

Event

2024 Event

Clear

Displaying 1,026 - 1,050 of 2,573

«
1
…
40
41
42
43
44
…
103
»

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy in Kidney & Bladder Cancer

By: Primo N. Lara, Jr., MD

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy in Kidney & Bladder Cancer

By: Primo N. Lara, Jr., MD

Radiotherapy & Immunotherapy Applications in Oncology

Radiotherapy & Immunotherapy Applications in Oncology

By: Puneeth Iyengar, MD, PhD

Immunotherapy in Head & Neck Cancer and What After IO Failure?

Immunotherapy in Head & Neck Cancer and What After IO Failure?

By: Robert Haddad, MD

Immunotherapy in Head & Neck Cancer and What After IO Failure?

Immunotherapy in Head & Neck Cancer and What After IO Failure?

By: Robert Haddad, MD

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy in Kidney & Bladder Cancer

By: Rohit Jain, MD

Immunotherapy in Kidney & Bladder Cancer

Immunotherapy in Kidney & Bladder Cancer

By: Rohit Jain, MD

Management of Common Toxicities Encountered With Checkpoint Inhibitors

Management of Common Toxicities Encountered With Checkpoint Inhibitors

By: Rosanna Rodriguez, PA-C

Immunotherapy for Melanoma

Immunotherapy for Melanoma

By: Sanjiv Agarwala, MD

Immunotherapy for Melanoma

Immunotherapy for Melanoma

By: Sanjiv Agarwala, MD

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Immunotherapy, Targeted Therapy & And What After in Melanoma?

By: Sanjiv Agarwala, MD

Immunotherapy, Targeted Therapy & And What After in Melanoma?

Immunotherapy, Targeted Therapy & And What After in Melanoma?

By: Sanjiv Agarwala, MD

Immunotherapy & targeted Therapy in Melanoma

Immunotherapy & targeted Therapy in Melanoma

By: Sanjiv Agarwala, MD

Immunotherapy & targeted Therapy in Melanoma

Immunotherapy & targeted Therapy in Melanoma

By: Sanjiv Agarwala, MD

Melanoma: Novel Advances in Immunotherapy

Melanoma: Novel Advances in Immunotherapy

By: Sanjiv Agarwala, MD, FASCO

Immunotherapy Session

Immunotherapy Session

By: Sanjiv Agarwala, MD; Pedro Barata, MD; Ahmed Zakari, MD; Pedro G. Solivan, MD

Promising Immunotherapy for Melanoma

Promising Immunotherapy for Melanoma

By: Sanjiv S. Agarwala, MD

Immunotherapy & Targeted Therapy in Melanoma

Immunotherapy & Targeted Therapy in Melanoma

By: Sanjiv S. Agarwala, MD

Immunotherapy and Targeted Therapy in Melanoma

Immunotherapy and Targeted Therapy in Melanoma

By: Sanjiv S. Agarwala, MD

Immunotherapy & Targeted Therapy in Melanoma

Immunotherapy & Targeted Therapy in Melanoma

By: Sanjiv S. Agarwala, MD

Promising Immunotherapy for Melanoma

Promising Immunotherapy for Melanoma

By: Sanjiv S. Agarwala, MD

Targeted Therapies in Cancer: Is Targeting the Same Mutation Relevant Across Histology and Tumor Type?

Targeted Therapies in Cancer: Is Targeting the Same Mutation Relevant Across Histology and Tumor Type?

By: Shivaani Kummar (OHSU)

Progress in CAR-T Cell Therapies

Progress in CAR-T Cell Therapies

By: Stephen Forman, MD

Progress in CAR-T Cell Therapies

Progress in CAR-T Cell Therapies

By: Stephen J. Forman, MD

Role of Interleukins in TIME to Improve Immunotherapy Efficacy

Role of Interleukins in TIME to Improve Immunotherapy Efficacy

By: Suresh Ramalingam, MD

«
1
…
40
41
42
43
44
…
103
»

Post navigation

← Previous View

© 2024 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok